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Abstract 
Background: The periaqueductal gray region (PAG) is one of several brain areas identified to be vulnerable to struc-
tural and functional change following peripheral nerve injury. Sciatic nerve constriction injury (CCI) triggers neuro-
pathic pain and three distinct profiles of changes in complex behaviours, which include altered social and sleep–wake 
behaviours as well as changes in endocrine function. The PAG encompasses subgroups of the A10 dopaminergic and 
A6 noradrenergic cell groups; the origins of significant ascending projections to hypothalamic and forebrain regions, 
which regulate sleep, complex behaviours and endocrine function. We used RT-PCR, western blots and immunohisto-
chemistry for tyrosine hydroxylase to determine whether (1) tyrosine hydroxylase increased in the A10/A6 cells and/
or; (2) de novo synthesis of tyrosine hydroxylase, in a ‘TH-naïve’ population of ventral PAG neurons characterized rats 
with distinct patterns of behavioural and endocrine change co-morbid with CCI evoked-pain.
Results: Evidence for increased tyrosine hydroxylase transcription and translation in the constitutive A10/A6 cells 
was found in the midbrain of rats that showed an initial 2–3 day post-CCI, behavioural and endocrine change, which 
recovered by days 5–6 post-CCI. Furthermore these rats showed significant increases in the density of TH-IR fibres in 
the vPAG.
Conclusions: Our data provide evidence for: (1) potential increases in dopamine and noradrenaline synthesis in vPAG 
cells; and (2) increased catecholaminergic drive on vPAG neurons in rats in which transient changes in social behavior 
are seen following CCI. The data suggests a role for dopaminergic and noradrenergic outputs, and catecholaminergic 
inputs of the vPAG in the expression of one of the profiles of behavioural and endocrine change triggered by nerve 
injury.
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Background
The relationships of injury, the sensation of pain and 
the affective-motivational pain state are not straightfor-
ward, because they are not wholly consequent upon each 
other. Nerve damage due to trauma, disease or surgical 
intervention does not always trigger a neuropathic pain 
state in humans [1]. There is also no simple relationship 
between pain intensity and reported disruptions to qual-
ity of life [2]. Further, there exists a, ‘non-patient chronic 
pain population’ that reports sensory dysfunction, but 
does not seek treatment and thus is ‘clinically invisible’. 
The patient population that does seek medical assistance 
for chronic pain conditions invariably presents with more 
than just sensory dysfunction. Their pain state in many 
cases includes problems with sleep [3–7] and impaired 
social functioning [7–9].
Problems with sleep, defined by measuring disrupted 
sleep–wake cycles, are also triggered by nerve injury 
in rat models of neuropathic pain (although c.f. [10]). 
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Spared nerve injury increases the frequency of episodes 
of wakefulness and slow-wave sleep [11]. Similarly, 
chronic constriction injury of the sciatic nerve (CCI) also 
disrupts the sleep–wake cycle, the nature of these dis-
ruptions depends upon the strain of the rat, the diurnal 
phase of measurement, the housing conditions, the post-
injury time of recordings and whether one or two nerves 
are ligated [12–14]. A unilateral CCI triggers increased 
wakefulness and decreased sleep from days 2 to days 10 
post-injury [12], a similar pattern is also reported fol-
lowing bilateral CCI at 7 days post injury [13]. We have 
also reported that CCI triggers sleep-wake cycle distur-
bances during the first week post-injury, and further we 
have reported that the patterns of these changes differ in 
distinct subgroups of rats. The sleep–wake cycle changes 
that we have reported correspond directly with changes 
in resident-intruder behaviours in a social-interactions 
test [14]. The sleep–wake cycle and behavioural changes 
were not driven by differing levels of sensory dysfunc-
tion as all rats showed identical degrees of increased 
sensitivity to mechanical and cold stimuli [14, 15]. The 
fact that sleep–wake cycle changes occurred only in ani-
mals whose resident intruder behaviour also changed 
corresponds with data in human populations show-
ing a correlation between sleep disturbances and social 
dysfunction(s) in neuropathic pain patients [3–7].
In detail, our data showed that CCI had no effect on 
sleep-wake cycles in approximately half of the rats given a 
CCI. Neither did these rats show changes in behaviour in 
the resident-intruder test [14, 15]. This group of rats was 
classified as having Pain alone. A second subgroup, of 
~30% of the rats, showed reduced slow-wave sleep (SWS) 
and increased wakefulness during both the dark and 
light phases, as well as reductions in dominance behav-
iours and increased non-social behaviours in the resi-
dent-intruder test. These rats were classified as Pain and 
Disability rats [14, 15]. The remaining CCI rats (~20%) 
showed reduced SWS and increased wakefulness during 
the light phase only, and a transient (2–3 day) reduction 
in dominance behaviour and increased non-social behav-
iour in the resident-intruder test, these rats were classi-
fied as Pain and Transient Disability rats [14, 15].
It has been shown that the duration and frequency of 
periods of wakefulness are regulated by dopamine (DA) 
containing neurons located in the ventral half of the peri-
aqueductal gray (PAG) [16]. This region encompasses the 
ventrolateral column of the periaqueductal gray (vlPAG) 
and the dorsal raphe nucleus (DRN). Increased activity 
of these DA containing neurons is suggested to regulate 
the activity of a specific population of hypothalamic neu-
rons, which prevent the switch between wakefulness and 
sleep states [16]. Furthermore, noradrenergic neurons in 
this same region that form part of the rostral extension of 
the A6 cell group [17] have also been shown to promote 
wakefulness in the rat [18]. In rats, evidence of significant 
impact of nerve injury on the PAG has been revealed in 
a number of studies, and it appears to be one of several 
CNS sites particularly vulnerable to the effects of periph-
eral nerve injury [19–21]. This vulnerability may be due 
in part to the substantial direct and somatotopically 
ordered inputs from peripheral nerve recipient regions of 
the spinal cord and brainstem [22]. It is possible there-
fore, that the different patterns of sleep–wake cycle 
changes observed in the Pain and Disability and Pain 
and Transient Disability rats after sciatic nerve CCI may 
be contributed to by: (1) selective increases in the activ-
ity of dopaminergic and or noradrenergic cells located in 
the ventral half of the PAG and/or; (2) de novo synthe-
sis of dopamine, or noradrenaline, in a ‘dopamine-naïve’ 
and “noradrenaline-naïve” populations of ventral PAG 
neurons.
The PAG encompasses the group of DA neurons, 
referred to as the dorso-caudal extension of the A10 
group (A10dc). This group includes neurons of the DRN, 
the vlPAG and also cells in the lateral column of the peri-
aqueductal gray (lPAG) [23–26]. A majority of the A10dc 
cell group neurons are found in the DRN, where they are 
co-located with serotonergic neurons. However, they 
share similar projection targets and electrophysiological 
properties to the A10 cells of the ventral tegmental area 
(VTA) [25, 27]. The PAG also encompasses, a small group 
of noradrenergic neurons described as the rostral exten-
sion of the A6 cell group [17].
Using RT-PCR and western blots, relative levels of 
transcription and translation of tyrosine hydroxylase 
were quantified in the ventral PAG, A10dc/A6 [ros-
tral] cell group region, to determine the effects of CCI 
6 days after injury, in rats with Pain alone, Pain and Dis-
ability and Pain and Transient Disability. The differences 
between these three behavioural sub-groups were then 
investigated using immunohistochemistry to determine 
the location/s of TH protein expression changes revealed 
using western blot analyses.
Results
Resident‑intruder testing
Replicating our previous findings, rats could be catego-
rised into three groups post-CCI based upon changes in 
their dominance and non-social behaviours in the resi-
dent-intruder, social interactions test [14, 19–21]. Of the 
55 rats that underwent CCI and daily resident-intruder 
testing, fifty-four percent (30/55) were classified as Pain 
alone, as their dominance behaviours in response to the 
presence of an intruder did not decrease significantly 
following nerve injury. Twenty-seven percent (15/55) 
showed persistent reductions in dominance levels 
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following the injury and were classified as Pain and Dis-
ability rats. Nineteen percent (10/55) rats showed a tran-
sient reduction in dominance levels in the first 2–3 days 
following injury but returned to pre-injury levels during 
days 4–6 and were classified as Pain and Transient Dis-
ability rats. These findings are summarised in Fig. 1.
There were no differences in the levels of dominance 
during the first 5  days of resident-intruder testing in 
any of the behavioural or control groups (F14,198 = 9.27, 
NS). The dominance levels in behavioural and sham 
controls did not differ throughout the eleven, day test-
ing period (see Fig.  1). Pain and Disability rats showed 
a reduction in dominance levels on both days 1–3 and 
4–6 post-injury in comparison to their pre-injury levels 
(F14,198 = 9.27, p < 0.001), as well as compared with domi-
nance levels throughout testing in each of the control 
groups (F14,198 = 9.27, p < 0.001). Pain and Transient Dis-
ability rats showed a significant reduction in dominance 
levels on days 1–3 post-injury compared with pre-injury 
levels (F14,198 = 9.27, p < 0.05), as well as each of the con-
trol groups (F14,198 = 9.27, p < 0.001 vs, behavioural con-
trols and p  <  0.01 vs, sham controls), dominance levels 
returned to pre-injury levels on days 4–6 post CCI. The 
slight, but non-significant reduction in dominance seen 
in Pain alone rats was attributable solely to a small reduc-
tion on the day following surgery.
Fig. 1 Levels of dominance behaviour before and after nerve injury. Top panel mean durations (in seconds) of dominance behaviour (±SEM) 
measured: pre-injury (days 3–5); days 1–3 post-injury and; days 4–6 post-injury in behavioural controls, sham surgery rats and rats with Pain alone, 
Pain and Disability and Pain and Transient Disability. Significance with respect to pre-injury days is shown ***p < 0.001 (ANOVA, and post hoc Fischer’s 
PLSD). Lower panel individual data for Pain alone, Pain and Disability and Pain and Transient Disability post-CCI behavioural groups. Data are expressed 
as the mean percentage change from pre-CCI levels for days 1–3 post-CCI and days 4–6 post-CCI. The shaded area indicates a 30% reduction from 
pre-injury dominance behaviours. Rats that showed no differences in their post-CCI dominance behaviour were defined as Pain alone rats. Rats with 
a decrease of at least 30% in the duration of their dominance behaviours on 4 or more of the 6 days post injury days were defined as Pain and Dis-
ability rats. The rats that showed a 30% or more reduction in their dominance behaviours for days 1–3 post-CCI but then returned to pre-CCI levels 
were considered Pain and Transient Disability rats.
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Real‑time RT‑PCR and Western blotting
Quantitative real time RT-PCR was used to determine 
relative TH mRNA expression and western blotting was 
used to determine relative TH protein expression levels 
in the midbrains of CCI and control rats; these results are 
presented in Fig. 2. Rats with Pain and Transient Disabil-
ity had increased levels of TH mRNA compared to each 
of the control groups (F4,32 = 4.95, p < 0.01) (Fig. 2a). The 
Western blots identified TH and beta-actin with single 
bands of ~60 kDa and ~43 kDa, respectively (Fig. 2c). TH 
protein levels were calculated with respect to the house-
keeping protein beta-actin; then the relative expression of 
TH in CCI and sham injured rats was expressed relative 
to behavioural controls (Fig. 2c). Pain and Transient Dis-
ability rats showed a significant increase in TH protein 
expression compared to both behavioural and sham con-
trols (F4,31 = 5.9, p < 0.01), and compared to Pain alone 
rats (F4,31 = 5.9, p < 0.05) (Fig. 2b).
Immunohistochemical analysis
In injured rats, TH-IR cells and fibers were observed in 
midbrain sections under the light microscope. TH-IR 
cell profiles were found in the intermediate lateral PAG; 
the ventrolateral PAG and the DRN (Fig.  3, top row). 
In all rats evaluated the largest numbers of TH-IR cells 
were found in the DRN at approximately −7.3 mm from 
bregma (Fig.  3, second row, column c). However these 
cell numbers did not differ between groups. TH-IR in 
the neurons of rats with Pain and Transient Disability 
was significantly greater than that in Pain alone rats at 
−7.3 mm from bregma (F11,48 = 5.443, p < 0.05) (Fig. 3, 
third row, column c). Further, rats with Pain and Tran-
sient Disability also showed increased densities of 
TH-IR fibers at 7.3 and 7.8 mm caudal to bregma, com-
pared to both Pain and Disability and Pain alone rats 
(F11,48 = 19.97, p < 0.001) (Fig. 3, fourth row, columns c, 
d).
Discussion
The aims of this study were to identify alterations in 
tyrosine hydroxylase expression in the ventral PAG 
6 days after sciatic nerve CCI, a time point at which we 
have shown that rats segregate into three distinct behav-
iourally defined groups, despite the presence of identi-
cal sensory disruptions in all rats. These groups are: (1) 
Pain and Disability, a subgroup in which dominance 
and non-social behaviour in the resident-intruder social 
interactions test, and sleep-wake cycles are disrupted; (2) 
Pain and Transient Disability, a subgroup in which CCI 
disrupted dominance and non-social behaviour in the 
resident-intruder social interactions test are restored to 
normal levels, but sleep–wake cycles in the light phase 
are disrupted and; (3) Pain alone a subgroup which expe-
rience no disruptions in either resident intruder interac-
tions or the sleep–wake cycle. Real-time RT-PCR and 
western blotting revealed increased TH expression, at 
both transcription and translation levels in the mid-
brain of rats with Pain and Transient Disability 6  days 
post-CCI. Systematic evaluation of staining for TH-IR 
in the midbrain revealed that the number and location 
of TH-IR cells in the vPAG region did not differ between 
CCI groups, but consistent with the western blotting 
Fig. 2 TH mRNA and protein expression in rats with distinct patterns 
of injury-triggered disability. Box and whisker plots showing: a relative 
TH mRNA expression and; b relative TH protein expression as deter-
mined by real-time RT-PCR and western blotting, respectively. Data 
are shown for behavioural controls (white); sham controls (green); Pain 
alone (yellow); Pain and Disability (blue); and Pain and Transient Disabil-
ity (pink). Significance with respect to behavioural controls and sham 
surgery controls are shown **p < 0.01 (one-way ANOVA, post hoc 
Bonferroni test). c Examples of two different western blots showing 
fluorescence for TH protein (60 KDa) and beta-actin (43 KDa). In each 
example gel specific examples of a protein sample from each control 
and experimental group, are indicated by a different coloured arrow: 
behavioural controls (white); sham controls (green); Pain alone (yel-
low); Pain and Disability (blue); and Pain and Transient Disability (pink). 
(We have shown entire gels in this figure, Pain alone rats in lanes e, f, g, 
h, I, k; Pain and Disability rats in lanes a, b, j; Pain and Transient Disability 
rats in lanes c, d, l; sham control rats in lanes m, n, o; and behavioural 
controls in lanes p, q).
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data, rats in the Pain and Transient Disability group had 
significantly greater densities of TH-IR fibres and sig-
nificantly greater intensity of TH immunoreactivity in 
vlPAG and DRN neurons [i.e., the A10dc and A6 (rostral) 
groups] than rats in the Pain alone and Pain and Disabil-
ity subgroups.
These data provide evidence for a selective increase 
in tyrosine hydroxylase expression in the constitutive 
vPAG TH-IR cell populations [A10dc and A6 (rostral) 
cell groups], and increased TH-IR in vPAG fibres, in rats 
that show an initial decrease in dominance and increase 
in non-social behaviours for the first 2–3  days after 
CCI, coupled with increased wakefulness and decreased 
slow-wave sleep during the light phase, a pattern we 
have reported previously [14] which we term Pain and 
Transient Disability. Increased TH-IR in the A10dc cell 
group likely indicates increased dopamine synthesis and 
increased TH-IR in the rostral A6 cells likely indicates 
increased noradrenaline synthesis. Our earlier reports 
of a selective increase in plasma corticosterone in Pain 
and Transient Disability rats on days 2 and 3 post-CCI 
[31] may reveal one mechanism by which TH mRNA 
can be selectively up-regulated in the vPAG of this 
behavioural subgroup [32]. Further, increased activity in 
Fig. 3 TH-expression in the vPAG of rats with distinct patterns of injury-triggered disability. Top row a–d shows photomicrographs of TH immunore-
activity in the vPAG under brightfield illumination. a −6.3 mm caudal to bregma; b −6.8 mm caudal to bregma; c, −7.3 mm caudal to bregma; and 
d −7.8 mm caudal to bregma. The scale bar represent 1.0 mm. Directly below each photomicrograph, box and whisker plots illustrate (1) the mean 
number (±SEM) of TH-IR cells; (2) the mean intensity (±SEM) of staining in TH-IR neurons and; (3) the mean density (±SEM) of TH-IR fibers, at each 
of these rostro-caudal levels of the vPAG in five rats from each of the behaviourally characterized groups. Significant differences between behav-
ioural groups is shown *p < 0.05 (2-way ANOVA, Bonferroni test).
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dopaminergic and noradrenergic projections originat-
ing in the vPAG may also contribute to these patterns of 
TH increase reported here [32, 33]. Finally, the increased 
density of TH-IR in fibres in the vPAG may reflect 
increased catecholaminergic drive in this area. We con-
sider each of these suggestions in turn.
The A10dc cells also have extensive ascending and 
largely non-collateralised projections into the ventrolat-
eral preoptic area and perifornical (orexinergic) lateral 
hypothalamus, midline and intralaminar thalamus, the 
central nucleus of the amygdala, the bed nucleus of the 
stria terminalis, the shell of the nucleus accumbens, the 
septum, the basal forebrain cholinergic nuclei and the 
medial prefrontal cortex (mPFC). As well, they project 
within the midbrain-pontine region to the lateral dorsal 
tegmental nucleus and the locus coeruleus [16, 23, 24, 
34]. The importance of these extensive projections in 
regulating the behavioural responses to environmentally 
salient stimuli is well known [35]. A role for the A10dc 
cells in resident intruder interactions is also suggested by 
observations that dopamine levels in the nucleus accum-
bens (NAc) and the mPFC increase during resident-
intruder interactions and these increases are sustained 
for up to 20–30 min. Further, daily resident-intruder test-
ing results in an anticipatory increase in dopamine in the 
NAc prior to the testing period [36, 37]. In rats with Pain 
and Transient Disability an increase in A10dc DA activ-
ity in cells which project into the NAc and mPFC may 
represent an increased drive to engage the intruder in 
the stereotyped behaviours disrupted by CCI in the early 
(days 1–3) post-CCI phase. This suggests that for the sub-
groups of rats in which, CCI disrupts resident-intruder 
behaviours (i.e., Pain and Disability and Pain and Tran-
sient Disability) there may be differential changes in 
dopamine responsiveness of the NAc and mPFC neu-
ronal populations which regulate social interactions 
between the two behavioural subgroups (see for example 
[38]).
Neurons of the vPAG are pivotal in the regulation of 
REM sleep and wakefulness. Inhibition of vPAG neu-
rons with microinjections of the GABA-a agonist mus-
cimol significantly increased the duration of REM sleep 
[39], and selective lesions of DA vlPAG neurons led to 
increased wakefulness [16, 40]. These vlPAG DA cells 
project into multiple loci of the sleep regulatory network, 
including the cholinergic neurons of the basal forebrain, 
the ventrolateral preoptic region, the orexin neurons of 
the lateral hypothalamus, the cholinergic pontine lat-
erodorsal tegmental nucleus and the locus coeruleus. 
Increased TH expression in the A10dc cells may con-
tribute to the disrupted sleep-wake cycle seen during the 
light phase in the Pain and Transient Disability rats, this 
mechanism appears to be different from that underlying 
the sleep-wake disturbances in Pain and Disability rats 
in which TH levels remained unchanged. Thus whilst 
we have provided evidence for changes in dopaminer-
gic activity in the A10dc group in a subset of CCI rats, 
changes in dopamine receptor expression in the target 
areas of these neurons following nerve injury requires 
more systematic evaluation.
The A6 noradrenergic cells found in the vPAG com-
prise the rostral cell group [17], this group of cells have 
been shown to be critical in regulating wakefulness and 
controlling levels of arousal and alertness [41], further 
they play a role in the regulation and promotion of social 
interactions [42]. Increased TH in this small group of 
cells may contribute to the restoration of normal resi-
dent intruder social interactions following post CCI days 
2–3, as well as regulating wakefulness during the light 
phase.
The non-somatic TH-IR in the vPAG may be located 
in either the dendrites of the immunoreactive neurons 
or in input terminals and fibres en passant originating 
in the catecholaminergic cell groups of the lower brain-
stem. Catecholaminergic cells, which project to the 
vPAG include the A1 and C1 cells of the ventrolateral 
medulla [43]; the A2 and C2 cell groups of the dorso-
medial medulla [44] and the A6 cells of the locus coer-
uleus [45]. Recent evidence indicates that CCI increases 
noradrenaline synthesis in the locus coeruleus [46, 47]. 
The extent to which a selective activation of ascending 
medullary adrenergic and noradrenergic pathways con-
tributes to the pattern of TH-IR in the vPAG of rats with 
Pain and Transient Disability remains to be established 
experimentally.
Methods
The approval of the University of Sydney Animal Care 
and Ethics Committee, following the guidelines of the 
NHMRC “Code for the Care and Use of Animals in 
Research in Australia”, the NSW Animal Research Act 
(2007) was given for these experiments, which also 
adhered to the “Ethical Guidelines for Investigations of 
Experimental Pain in Conscious Animals” laid down by 
the International Association for the Study of Pain [28].
Behavioural testing
Outbred, male Sprague–Dawley rats, 250–350  g at the 
time of surgery (ARC Perth, WA, Australia) were used in 
these experiments. They were maintained on a reversed 
12/12 light/dark cycle with food and water available 
ad  libitum. Room temperature was maintained at 22 
(±1)°C. Behavioural tests were conducted during the 
dark phase of the circadian cycle.
‘Resident-intruder’ testing was performed as described 
by Monassi and colleagues [14]. Briefly, rats were 
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individually housed in clear perspex cages for 7 days (the 
‘resident’). For the next 6  days, approximately 2  h after 
lights off, a novel, age and weight matched ‘intruder’ 
was introduced into the cage and the resulting social 
interactions were video-recorded for a period of 6  min 
(pre-CCI). On the next day, the resident rat was given a 
sciatic nerve CCI (see below), and a day later, the resi-
dent intruder testing continued for a further 6 days (post 
CCI). The behaviours of the resident rats, in response to 
the intruder were scored, and the durations of four mutu-
ally exclusive categories of behaviour (dominance, social, 
non-social and submissive) were quantified.
On day 6 post-CCI, rats were either decapitated rapidly 
under CO2 narcosis, and the brains removed immedi-
ately, snap frozen in liquid nitrogen and stored at −80°C 
until assayed (N = 52), or they were deeply anaesthetized 
with sodium pentobarbitone (Nembutal: 120 mg/kg i.p.) 
and perfused intra-cardially with 0.9% saline (500  ml 
room temperature) followed by 4% paraformaldehyde in 
phosphate buffer (pH 7.4, 4°C) (N = 15)
Behavioural analyses
Resident behaviours in the 6 days following sciatic nerve 
constriction injury were compared to those in the 3 days 
prior to injury (i.e. pre-CCI days 3–5). On the basis of 
these comparisons, rats were categorised into one of 
three distinct behavioral groups. Rats that showed no 
differences in their behaviour following CCI were con-
sidered Pain alone rats; rats with a decrease of at least 
30% in the duration of their dominance behaviours in 4 
of the 6 days post injury days were classified as Pain and 
Disability rats. The rats that showed an initial reduc-
tion in their dominance behaviours for the first 3–4 days 
but then returned to pre-CCI levels by day 6 were con-
sidered Pain and Transient Disability rats. The dura-
tion of time spent in each category of resident-intruder 
behaviour for each behavioural group were expressed 
as means ±  (SEM). Comparisons between groups were 
made with a two-way ANOVA and significant differences 
between groups were determined post hoc using Fis-
cher’s protected least significance difference (PLSD) test.
Sciatic nerve CCI
Sciatic nerve chronic constriction injuries were per-
formed, by following exactly the procedure described by 
Bennett and Xie [29]. Under halothane anaesthesia (2% 
in oxygen) the right sciatic nerve was exposed by gentle 
blunt dissection. Four chromic gut ligatures were tied 
loosely around the sciatic nerve approximately 1  mm 
apart. The overlying muscles were closed, the skin inci-
sion sutured and the wound dusted with topical antibi-
otic powder (Tricin).
Control groups
Two groups of control rats were used in these experi-
ments. Sham controls (N  =  6) underwent resident-
intruder testing as well as sham surgery in which they 
were placed under halothane anaesthesia (2% in oxygen) 
and the sciatic nerve was exposed but no CCI was per-
formed. Behavioural controls (N = 24) received daily res-
ident-intruder testing but were not anaesthetised neither 
did they experience any surgical procedures. Twenty-four 
behavioural control rats were used to compare with the 
26 rats that received CCI and were subsequently pro-
cessed for RT-PCR and western blots.
Following the last day of resident-intruder testing, rats 
were either rapidly decapitated [N = 56: (Pain alone = 11; 
Pain and Disability  =  10; Pain and Transient Disabil-
ity =  5; Behavioural Control =  24; Sham Control =  6)] 
and the brains removed and stored in −80°C until used, 
or they were deeply anaesthetised with sodium pento-
barbitone (i.p., Nembutal 120 mg/kg) and perfused tran-
scardially with 500 ml of heparinised 0.9% saline at room 
temperature, followed by fixation with 600 ml of 4% para-
formaldehyde in phosphate buffer (pH 7.4; 4°C) [N = 15: 
(Pain alone = 5; Pain and Disability = 5; Pain and Tran-
sient Disability = 5)].
Real‑time RT‑PCR
A dorsal midbrain block encompassing the PAG and 
DRN was isolated from each of the frozen brains. The 
rostral boundary of this block was at the approximate 
coronal level of −5.3  mm caudal to bregma and the 
caudal boundary at approximately −8.8  mm caudal to 
bregma [30]. The PAG region surrounding the mesen-
cephalic aqueduct was dissected free under a binocular 
microscope, weighed and total RNA of the isolated tis-
sue was extracted using TRI reagent (Sigma-Aldrich). 
RNA concentrations were calculated using spectropho-
tometry (ND-1000 spectrophotometer, NanodropTH, 
Wilmington, DE, USA) and RNA integrity was verified 
using the 2100 Bioanalyser (Agilent Technologies™, 
Santa Clara, CA, USA). 1 μg of total RNA was used for 
cDNA synthesis (Tetro Reverse transcriptase, Bioline, 
Australia). Relative expression levels of TH mRNA were 
determined using TaqMan® FAM probe with TAMRA 
as the quencher dye (Rn00561369_m1). GAPDH was 
used simultaneously as a housekeeping gene using a VIC 
probe with MGB as the quencher dye (product Number 
4352338E).
Western blotting
Protein was isolated from the organic phase in the TRI 
reagent protocol. Total protein concentrations for each 
midbrain block were estimated using the Direct Detect™ 
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Spectrometer (Millipore, Bedford, MA, USA). 15  μg 
of total protein was then separated on 12% Criterion 
TGX stain-Free gels (Bio-Rad) and transferred to PVDF 
membranes using the trans-Blot® Turbo Transfer packs 
(Bio-Rad). Membranes were blocked in skim milk pow-
der (5%) and incubated overnight at 4°C with a mouse 
monoclonal anti-TH antibody (1:10,000, ImmunoStar), 
followed by incubation with HRP-conjugated goat anti-
mouse IgG (1:5,000, Santa Cruz). TH was visualised 
using the Immobilon Western chemiluminescence HRP 
substrate (Millipore, Bedford, MA, USA) on a ChemiDoc 
MP imaging system (Bio-Rad). Bands were quantified 
using Image Lab™ software.
Membranes were then incubated in rabbit polyclonal 
anti-beta actin antibody (1:1,000, Santa Cruz) followed 
by HRP-conjugated goat anti-rabbit IgG (1:5,000, Santa 
Cruz). The labeled beta actin was visualised and quanti-
fied as described above.
Immunohistochemistry
Following transcardial perfusion with fixative, the brains 
of each rat were removed and post-fixed overnight in 4% 
paraformaldehyde (4°C) and then placed in 30% sucrose 
in 0.1  M phosphate saline buffer (PBS) at 4°C until the 
brains sank. A one in ten series of 20 μm sections were 
cut through from −5.8 to −8.8 mm from bregma using 
a freezing microtome (Leica, Germany). All sections 
were treated identically and were reacted at each stage, 
for exactly the same time. Sections were incubated in 3% 
H2O2 to block endogenous peroxidase activity, blocked 
in 10% normal horse serum (NHS) and 0.3% triton-X in 
PBS and then incubated in a mouse monoclonal anti-TH 
antibody (1:10,000, ImmunoStar) at 4° overnight. Sec-
tions were washed in PBS then incubation in biotinylated 
donkey anti-mouse IgG (1:500; Jackson Immunochemi-
cals, West Grove, PA, USA) for 2 h. Following a wash in 
PBS, the sections were then incubated in ExtrAvidin per-
oxidase (1:1,000; Sigma-Aldrich, St. Louis, MO, USA) for 
2  h. The bound antibody complex was visualised using 
DAB (0.05%) as the chromagen. Sections were mounted 
onto gelatinized slides; allowed to dry overnight; dehy-
drated through graded alcohols and then coverslipped 
with DPX mounting medium.
Image analysis
Analysis of tyrosine hydroxylase immunoreactivity 
(TH-IR) was done under the light microscope (Olym-
pus BX51). In each rat (N =  15), the number of TH-IR 
neurons was counted on coronal sections corresponding 
to atlas sections from the atlas of Paxinos and Watson 
[30] at 6.3, 6.8, 7.3 and 7.8 mm caudal to the skull mark-
ing bregma. The staining intensity of the TH-IR neurons 
and the density of TH-IR fibers on each of these sections 
were calculated using Metamorph® (Molecular Devices, 
Inc). A digital image of each section at 100× magnifica-
tion was captured under identical illumination and reso-
lution using a light microscope (Olympus BX) and digital 
camera (Olympus DP70). Each image was opened in the 
Metamorph® software and colour thresholding was used 
to selectively highlight TH-IR neuronal cell bodies. Inte-
grated morphometry analysis was then used to deter-
mine the average intensity of the TH-IR cell population, 
normalised against background staining. Following 
this, in a randomly selected section the color threshold-
ing function was used to identify the threshold range of 
non-somatic i.e., fibre and dendrite TH-IR. This thresh-
old range was then applied to all sections to quantify the 
density of non-somatic TH-IR.
Comparisons of TH-IR cell numbers, TH-IR intensity 
in neurons and TH-IR density in non-somatic structures 
were made between the behavioural groups (Pain alone, 
Pain and Disability and Pain and Transient Disabil-
ity) across the rostro-caudal levels (6.3, 6.8, 7.3, 7.8 mm 
caudal to bregma) using a one-way ANOVA, and when 
significance was found, the specific locations of the dif-
ferences were determined by interrogating the data using 
the Bonferroni post hoc test. Statistical significance was 
set as p < 0.05.
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